跳至主要内容
临床试验/NCT07612865
NCT07612865已完成不适用

People's Hospital of Xinjiang Uygur Autonomous Region

People's Hospital of Xinjiang Uygur Autonomous Region1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2022年9月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
160
试验地点
1

研究概览

简要总结

Objective: To evaluate the impact of enhanced recovery after surgery (ERAS)-based nursing intervention on venous thromboembolism (VTE) and lymphedema after radical hysterectomy for cervical cancer.

Methods: In this prospective randomized controlled trial, 160 patients scheduled for radical hysterectomy during September 2022-September 2024 were randomized to an ERAS group (n = 80) or a control group (n = 80). The control group received conventional perioperative care, while the ERAS group received a multimodal perioperative care protocol. Primary outcomes were the 6-month incidence of VTE and lower limb lymphedema. Secondary outcomes included recovery indicators, inflammatory and coagulation markers, quality of life [QoL; assessed by the Quality of Life Questionnaire-Core 30 (QLQ-C30)], and nursing satisfaction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • . Pathologically confirmed cervical cancer (FIGO 2018)
  • Age 18-70 years
  • First-time radical hysterectomy
  • ASA physical status class I-II
  • Perioperative anticoagulant prophylaxis per hospital standards
  • Provision of informed consent

排除标准

  • 1. Pre-existing lower extremity DVT, lymphedema, or severe varicose veins
  • Severe cardiac, hepatic, or renal dysfunction or coagulation disorders
  • History of psychiatric illness or communication barriers
  • Pregnant or lactating women

研究者

发起方
People's Hospital of Xinjiang Uygur Autonomous Region
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiumin Zhang

Principal Investigator

People's Hospital of Xinjiang Uygur Autonomous Region

研究点 (1)

Loading locations...

相似试验